Skip to main content
    U

    Upstream Bio, Inc. (UPB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.10
    -0.05 (-2.33%)

    Market Cap: $117.84M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Upstream Bio, Inc. (UPB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Upstream Bio (UPB) has a market cap of $117.84M and an enterprise value of $70.43M. It kept -5712.33% of revenue as net income over the last 12 months. It holds $47.42M more cash than debt, 40.24% of its market cap.

    Total Valuation

    Enterprise value is 40.24% below the market cap, as cash exceeds debt.

    Market Cap$117.84M
    Enterprise Value$70.43M
    Latest price (Nov 17, 2026)$2.10

    Key Dates

    The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 24, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.39% in the quarter ended Sep 30, 2026 and grew 325.69% a year over 2 years.

    Shares Outstanding54.78M
    Shares Change (YoY)+1.58%
    Shares Change (QoQ)+0.39%
    Share Count Growth (2Y CAGR)+325.69%

    Valuation Ratios

    Sales and book value multiples are 40.1x and 0.5x.

    P/S Ratio40.1x
    Forward P/S47.7x
    P/B Ratio0.5x

    Price Statistics

    The stock is down 91.44% over 52 weeks and trades 48.53% below its 50-day average.

    Beta (1Y)1.83
    52-Week Change-91.44%
    1-Month Change-25.00%
    3-Month Change-72.06%
    6-Month Change-73.85%
    Total Return (1Y)-91.44%
    Return vs SPY (1Y)-103.34%
    Max Drawdown (1Y)-93.56%
    Max Drawdown (3Y)-93.56%
    Sharpe Ratio (1Y)-2.33
    Correlation with SPY (1Y)0.23
    50-Day Average$4.08
    200-Day Average$7.60
    52-Week Range$2.12 to $33.68
    RSI (14 Days)27.6
    Average Volume (20 Days)1.30M

    Price chart

    Financial Position

    Current assets cover 20.45x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio20.45x
    Quick Ratio20.45x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -70.07% and return on assets is -66.65% over the last 12 months.

    Return on Equity (ROE)-70.07%
    Return on Assets (ROA)-66.65%
    Asset Turnover0.01x
    Receivables Turnover4.92x

    Scores

    UPB has an Altman Z-Score of 1.94, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score1.94
    Altman Z ZoneGrey
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $2.87M over the last 12 months is up 2.54% from the 12 months before.

    Revenue$2.87M
    Revenue Growth (YoY)+2.54%
    Gross Profit$2.87M
    Operating Income-$175.53M
    Pretax Income-$163.94M
    Net Income-$163.94M
    Reported EPS (TTM)-$3.01

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 95.11% of the $245.99M in total assets.

    Cash and Equivalents$47.42M
    Total Debt$0
    Net Cash$47.42M
    Net Cash Per Share$0.87
    Working Capital$232.67M
    Shareholder Equity$233.97M
    Book Value Per Share$4.27
    Total Assets$245.99M
    Total Liabilities$12.02M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$168.33M
    FCF Per Share-$3.07
    Depreciation and Amortization$2.79M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -6115.99%.

    Gross Margin100.00%
    Operating Margin-6115.99%
    Pretax Margin-5712.33%
    Net Margin-5712.33%

    Dividends and Yields

    UPB does not pay a dividend.

    Buyback Yield-0.06%
    Shareholder Yield-0.06%

    Peer Position

    Against 7 similar companies, UPB has the 4th highest P/S.

    P/S Ratio40.1x vs 16.9x median
    Revenue Growth (Trailing 4 Quarters, YoY)+2.54% vs -46.46% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About UPB

    What is UPB's market cap?

    Upstream Bio has a market cap of $117.84M. Its enterprise value, which adds debt and subtracts cash, is $70.43M.

    How many shares of UPB are outstanding?

    Upstream Bio has 54.78M shares outstanding. The count is up 1.58% from a year earlier.

    Does UPB pay a dividend?

    No. Upstream Bio does not pay a dividend.

    How much debt does UPB have?

    Upstream Bio has $0 of total debt and $47.42M of cash and equivalents, a net cash position of $47.42M.